REG3A antibody
Principal name
REG3A antibody
Alternative names for REG3A antibody
REG-3-alpha, Reg III-alpha, HIP, PAP, PAP1, Human proislet peptide, Pancreatitis-associated protein 1, Regenerating islet-derived protein 3-alpha, Regenerating islet-derived protein III-alpha
Ncbi ID
9606, NP_002571, NP_002571.1, NP_620354, NP_620355, NM_011259, NM_001145846, NM_002580, NM_138937, NM_138938
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Flow Cytometry (F)
Background of REG3A antibody
REG3A encodes a pancreatic secretory protein that may be involved in cell proliferation or differentiation. It has similarity to the C-type lectin superfamily. The enhanced expression of this protein is observed during pancreatic inflammation and liver carcinogenesis.
Function: Bactericidal C-type lectin which acts exclusively against Gram-positive bacteria and mediates bacterial killing by binding to surface-exposed carbohydrate moieties of peptidoglycan. Regulates keratinocyte proliferation and differentiation after skin injury via activation of EXTL3-PI3K-AKT signaling pathway.
Tissue Location: Highly expressed in epidermal keratinocytes of psoriasis patients (at protein level). Constitutively expressed in intestine. Low expression is found in healthy pancreas Overexpressed during the acute phase of pancreatitis and in some patients with chronic pancreatitis.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA332505 | REG3A antibody |
||||||
| Rabbit anti-REG3A Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu |
0.1 mg /
€335.00
|
||
| OriGene Technologies, Inc. | |||||||
| AP53629PU-N | REG3A (N-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | F, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
 +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP307791 | REG3A (transcript variant 1) |
||||
| Recombinant protein of human regenerating islet-derived 3 alpha (REG3A), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP316966 | REG3A (transcript variant 3) |
||||
| Recombinant protein of human regenerating islet-derived 3 alpha (REG3A), transcript variant 3 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP323860 | REG3A (transcript variant 2) |
||||
| Recombinant protein of human regenerating islet-derived 3 alpha (REG3A), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR220033L2V | Lenti ORF particles, Reg3a (GFP-tagged) - Mouse regenerating islet-derived 3 alpha (Reg3a), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR220033L1V | Lenti ORF particles, Reg3a (Myc-DDK-tagged) - Mouse regenerating islet-derived 3 alpha (Reg3a), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR200187L1V | Lenti ORF particles, Reg3a (Myc-DDK-tagged ORF) - Rat regenerating islet-derived 3 alpha (Reg3a), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||